No matter who you are, whether you are sick or well, you just breathe through our mask normally for one minute, and we analyze a mixture of inhaled and exhaled gases, to discover changes in your health, providing accurate data for use in check-ups, urgent medical situations, drug therapy assessment and even athletic training, to proactively improve your health and wellbeing.
140 W. Chestnut Ave. Monrovia, CA 91016
S.A.F.E. investing document available upon request.
Dragorosso’s technology was invented by the founders of the Oak Crest Institute of Science, where they work with the most distinguished academic research partners.
Dragorosso completed their first round of clinical study several years ago and is currently about to embark on further clinical studies in 2023 with ten major research partners. These studies will provide ample evidence of the accuracy and merit of the Dragorosso technology
Dragorosso is the assignee of the original patent covering the device. Dragorosso will apply for a new patent in 2023, extending the protection of the family of technologies.
Dragorosso's One Minute Test can:
Our non-invasive one minute exam is simple and provides more data on cardiac output over any other exam on the market.
We have secured a crucial patent pertaining to our groundbreaking testing technology. Patent detail available upon request.
Real individual data to study Dragorosso's effectiveness available. See Study Paper.
Chief Executive Officer
BSc. in electrical engineering from Imperial College with repeated success in founding and leading VC and PE backed technology startups to exits for investors by acquisition or going public. Expert at managing growth of technology startups to exit
Chief Science Officer
Ph.D. in organic chemistry from Imperial College, extensive record as principal investor on federally and locally funded research grants and contracts, including NIH, NSF, Dept. of Defense, Dept. of Agriculture, AQMD, HEI, etc. Co-founder of Oak Crest Institute of Science. Expert in spectroscopy, instrumentation design, clinical trial design and implementation, regulatory affairs
Chief Technology Officer
Ph.D. in chemistry from UNC, Chapel Hill, postdoctoral fellow at Caltech in Engineering and Applied Science. Co-founder of Oak Crest Institute of Science. Principal investigator on NIH and NSF research grants. Expert at laser spectroscopy, optical and analytical instrumentation design and development, optomechanical device miniaturization, advanced manufacturing techniques, and cardiopulmonary chemistry
Healthy people think of the heart as a reliable pump that can have disastrous failures if we don’t manage our health. Good enough to last a lifetime, but easily damaged by bad choices with behavior, diet, and drugs. Using technology, we will improve our medical approach to cardiac care, improving lives, reducing costs, and avoiding bad outcomes.